Literature DB >> 27045564

The burden of venipuncture pain in neonatal intensive care units: EPIPPAIN 2, a prospective observational study.

Emilie Courtois1, Patricia Cimerman2, Valérie Dubuche3, Marie-France Goiset4, Claire Orfèvre5, Audrey Lagarde6, Betty Sgaggero7, Céline Guiot8, Mélanie Goussot9, Etienne Huraux10, Marie-Christine Nanquette11, Céline Butel12, Anne-Marie Ferreira13, Sylvie Lacoste14, Sandrine Séjourné15, Valérie Jolly16, Gladys Lajoie17, Valérie Maillard18, Romain Guedj19, Hélène Chappuy20, Ricardo Carbajal21.   

Abstract

BACKGROUND: Newborns in intensive care units (ICUs) undergo numerous painful procedures including venipunctures. Skin-breaking procedures have been associated with adverse neurodevelopment long-term effects in very preterm neonates. The venipuncture frequency and its real bedside pain management treatment are not well known in this setting.
OBJECTIVES: To describe venipuncture frequency, its pain intensity, and the analgesic approach in ICU newborns; to determine the factors associated with the lack of preprocedural analgesia and with a high pain score during venipuncture.
DESIGN: Further analysis of EPIPPAIN 2 (Epidemiology of Procedural Pain In Neonates), which is a descriptive prospective epidemiologic study.
SETTING: All 16 neonatal and pediatric ICUs in the Paris region in France. PARTICIPANTS: All newborns in the ICU with a maximum corrected age under 45 weeks of gestation on admission who had at least one venipuncture during the study period.
METHODS: Data on all venipunctures, their pain score assessed with the DAN scale and their corresponding analgesic therapies were prospectively collected. The inclusion period lasted six weeks, from June 2, 2011, to July 12, 2011. Newborns were followed from their admission to the 14th day of their ICU stay or discharge, whichever occurred first.
RESULTS: 495 newborns who underwent venipunctures were included. The mean (SD) gestational age was 33.0 (4.4) weeks and duration of participation was 8.0 (4.5) days. A total of 257 (51.9%) neonates were very preterm (<33 weeks). The mean (SD; range) number of venipunctures per neonate during the study period was 3.8 (2.8; 1-19) for all neonates and 4.1 (2.9; 1-17) for neonates <33 weeks. Of the 1887 venipunctures, 1164 (61.7%) were performed successfully in one attempt, 437 (23.2%) with continuous analgesia, 1434 (76.0%) with specific preprocedural analgesia. In multivariate models, lack of preprocedural analgesia was associated with higher disease-severity score, intrauterine growth retardation, invasive or noninvasive ventilation, venipuncture performed on the first day of hospitalization or at nighttime, and the use of continuous sedation/analgesia. High pain scores were significantly associated with absence of parents during procedures, surgery during the study period, and higher number of attempts.
CONCLUSIONS: Venipuncture is very frequent in preterm and term neonates in the ICUs. 76% were performed with preprocedural analgesia. Strategies to reduce the number of attempts and to promote parental presence seem necessary.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiology; Intensive care unit; Neonate; Nursing care; Pain; Pain management; Procedural pain; Venipuncture

Mesh:

Year:  2016        PMID: 27045564     DOI: 10.1016/j.ijnurstu.2016.01.014

Source DB:  PubMed          Journal:  Int J Nurs Stud        ISSN: 0020-7489            Impact factor:   5.837


  8 in total

1.  The impact of cumulative pain/stress on neurobehavioral development of preterm infants in the NICU.

Authors:  Xiaomei Cong; Jing Wu; Dorothy Vittner; Wanli Xu; Naveed Hussain; Shari Galvin; Megan Fitzsimons; Jacqueline M McGrath; Wendy A Henderson
Journal:  Early Hum Dev       Date:  2017-03-23       Impact factor: 2.079

2.  The number of injected same-day preschool vaccines relates to preadolescent needle fear and HPV uptake.

Authors:  Amy L Baxter; Lindsey L Cohen; Mark Burton; Anaam Mohammed; M Louise Lawson
Journal:  Vaccine       Date:  2017-06-21       Impact factor: 3.641

3.  Practices of Procedural Pain Management in Neonates through Continuous Quality Improvement Measures.

Authors:  Jigar P Thacker; Deep S Shah; Dipen V Patel; Somashekhar M Nimbalkar
Journal:  Int J Pediatr       Date:  2022-02-13

4.  A complex interprofessional intervention to improve the management of painful procedures in neonates.

Authors:  Colette Balice-Bourgois; Christopher J Newman; Giacomo D Simonetti; Maya Zumstein-Shaha
Journal:  Paediatr Neonatal Pain       Date:  2020-01-13

5.  Usability, acceptability, and feasibility of the Implementation of Infant Pain Practice Change (ImPaC) Resource.

Authors:  Mariana Bueno; Bonnie Stevens; Megha Rao; Shirine Riahi; Alexa Lanese; Shelly-Anne Li
Journal:  Paediatr Neonatal Pain       Date:  2020-05-30

Review 6.  Management of comfort and sedation in neonates with neonatal encephalopathy treated with therapeutic hypothermia.

Authors:  Christopher McPherson; Adam Frymoyer; Cynthia M Ortinau; Steven P Miller; Floris Groenendaal
Journal:  Semin Fetal Neonatal Med       Date:  2021-06-23       Impact factor: 3.926

7.  A cluster randomized clinical trial to evaluate the effectiveness of the Implementation of Infant Pain Practice Change (ImPaC) Resource to improve pain practices in hospitalized infants: a study protocol.

Authors:  Mariana Bueno; Bonnie Stevens; Melanie A Barwick; Shirine Riahi; Shelly-Anne Li; Alexa Lanese; Andrew R Willan; Anne Synnes; Carole A Estabrooks; Christine T Chambers; Denise Harrison; Janet Yamada; Jennifer Stinson; Marsha Campbell-Yeo; Melanie Noel; Sharyn Gibbins; Sylvie LeMay; Wanrudee Isaranuwatchai
Journal:  Trials       Date:  2020-01-06       Impact factor: 2.279

8.  Study protocol: parents as pain management in Swedish neonatal care - SWEpap, a multi-center randomized controlled trial.

Authors:  Emma Olsson; Martina Carlsen Misic; Randi Dovland Andersen; Jenny Ericson; Mats Eriksson; Ylva Thernström Blomqvist; Alexandra Ullsten
Journal:  BMC Pediatr       Date:  2020-10-12       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.